$ABBV Recent Headlines Tesla cleared in German

New Post Public Reply Private Reply Replies (0) Message Board

Dec 3, 2013 at 3:34 PM

$ABBV Recent Headlines

Tesla cleared in German probe; Apple up on UBS upgrade
13 min ago3:20 p.m. Dec. 3, 2013
- Sue Chang

FDA approving drugs faster, and it may stay that way, report says

6:10 p.m. Nov. 18, 2013
- Russ Britt

AbbVie shares up on Hepatitis C results, but gains may be muted

11:49 a.m. Nov. 18, 2013
- Russ Britt

Mixed bag of earnings ends up badly for two health-care firms

10:22 a.m. Oct. 25, 2013
- Russ Britt

Microsoft, Amazon, Zynga are stocks to watch
4:31 a.m. Oct. 25, 2013
- Sue Chang

FDA recommends new limits on pain drugs
10:25 p.m. Oct. 24, 2013
- Thomas M. Burton

Abbott Labs sets a brisk earnings pace by beating income forecasts

10:43 a.m. Oct. 16, 2013
- Russ Britt

AbbVie net falls 16% on separation costs
8:58 a.m. July 26, 2013
- MarketWatch.com

4 things traders should know for the next 24 hours

4:46 p.m. July 25, 2013
- blogs.marketwatch.com

The Next 24: Starbucks Surges
4:13 p.m. July 25, 2013
- MarketWatch

Pharmacyclics seeks fast-track drug approval, makes double-digit gain

10:09 a.m. July 10, 2013
- Russ Britt

European regulators set precedent with approval of new copycat drugs

2:04 p.m. June 28, 2013
- Russ Britt

No rest for the weary, or even the savvy, in Wall Street carnage

4:21 p.m. June 20, 2013
- Russ Britt

Supreme Court satisfies few with ruling on generic drug settlements

4:30 p.m. June 18, 2013
- Russ Britt

Dan Loeb's cheap stock picks
11:39 a.m. June 18, 2013
- Insider Monkey

Pacts that delay sale of generics in jeopardy
1:55 a.m. June 18, 2013
- Brent Kendall

Supreme Court decision on generics hits Actavis, but few other drug firms

11:46 a.m. June 17, 2013
- Russ Britt

Abbott unveils $3 billion share-buyback program
2:22 p.m. June 14, 2013
- MarketWatch.com

Quant King Renaissance Technologies' stock picks
1:37 p.m. June 7, 2013
- Insider Monkey

Insiders and Dan Loeb like these stocks
11:00 a.m. June 4, 2013
- Insider Monkey

Pfizer out, AbbVie in on Goldman's CL-Buy list

8:45 a.m. Today8:45 a.m. Dec. 3, 2013
- Seeking Alpha

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More
8:29 a.m. Today8:29 a.m. Dec. 3, 2013
- 247WallSt.com

Investors Expect too Much of Salix

6:00 a.m. Dec. 2, 2013
- TheStreet.com

SDY Can Still Make You Money

4:21 p.m. Nov. 30, 2013
- Seeking Alpha

Health Canada Approves HUMIRA® (adalimumab) for the Treatment of Ulcerative Colitis (UC)
7:55 a.m. Nov. 28, 2013
- CNW Group

J&J's Olysio Approved in the U.S. - Analyst Blog

7:01 p.m. Nov. 26, 2013
- Zacks.com

A Look At Abbott's Vascular Division

3:29 p.m. Nov. 25, 2013
- Seeking Alpha

Achillion Pharmaceuticals: 3 Different Insiders Have Purchased Shares This Month

8:59 a.m. Nov. 25, 2013
- Seeking Alpha

Gilead And AbbVie Battle For Top Spot In $20 Billion Hepatitis Drug Market

4:37 a.m. Nov. 24, 2013
- Seeking Alpha

Gilead Hepatitis C Drug Wins EU Panel Vote Early

10:28 a.m. Nov. 22, 2013
- Investors Business Daily

Sanofi, Regeneron report good results for arthritis drug

7:07 a.m. Nov. 22, 2013
- Seeking Alpha

Biotech Stock Mailbag: Enanta, Vanda, Pharmacyclics, Top 2014 Stock Catalysts

6:00 a.m. Nov. 22, 2013
- TheStreet.com

New Research And Competition Could Hurt AbbVie's Other Blockbuster

12:21 p.m. Nov. 21, 2013
- Seeking Alpha

Celgene Vs. Rivals In Psoriatic Arthritis Drug Race

4:16 a.m. Nov. 20, 2013
- Seeking Alpha

AbbVie Reports HCV Trial Results - Analyst Blog

7:08 p.m. Nov. 19, 2013
- Zacks.com

European Approval for Gilead's Vitekta - Analyst Blog

11:40 a.m. Nov. 19, 2013
- Zacks.com

Celgene's Revlimid: Sales To $8B? Patent To 2023?

11:02 a.m. Nov. 19, 2013
- Seeking Alpha

6 Value Dividend Stocks You Should Consider For Your Portfolio

9:43 a.m. Nov. 19, 2013
- Seeking Alpha

AbbVie Hepatitis C Treatment Shines In Latest Trials

12:06 p.m. Nov. 18, 2013
- Investors Business Daily

AbbVie Hepatitis C Drug Shows Promise

10:04 a.m. Nov. 18, 2013
- WSJ.com

Product Recalls, New Appointments, Awareness Campaigns, and Stock Price Movements - Research Report on Abbott, AbbVie, Viropharma, Valeant Pharmaceuticals, and Salix Pharmaceuticals
8:00 a.m. Dec. 2, 2013
- PR Newswire

AbbVie Partners with HIV Community to Launch International Awareness Campaign Focused on Women Living with HIV
9:21 a.m. Nov. 26, 2013
- PR Newswire

Grants and Stock Movements of Major Drug Manufacturers - Research Report on AbbVie, Keryx Biopharmaceuticals, Pacira Pharmaceuticals, Rockwell Medical, and Impax Laboratories
8:00 a.m. Nov. 22, 2013
- PR Newswire

Federal Legislation Support, Philanthropic Activities, and Patent Challenges - Research Report on Mylan, Abbott, Actavis, AbbVie, and Agilent Technologies
8:00 a.m. Nov. 19, 2013
- PR Newswire

Today's Research: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc.
6:21 p.m. Nov. 14, 2013
- PR Newswire

AbbVie to Present at Jefferies 2013 Healthcare Conference
8:15 a.m. Nov. 14, 2013
- PR Newswire

Critical Alerts For Johnson and Johnson, AbbVie, Air Products and Chemicals, American Capital, and AFLAC Released By InvestorsObserver
9:31 a.m. Nov. 13, 2013
- PR Newswire

Financial Results, New Drug Applications, and Stock Price Movements - Research Report on Endo, Bristol-Myers Squibb, Express Scripts, AbbVie, and Incyte
8:00 a.m. Nov. 8, 2013
- PR Newswire

AbbVie to Present at Credit Suisse 2013 Healthcare Conference
8:15 a.m. Nov. 7, 2013
- PR Newswire

Clinical Studies, Regulatory Clearance, Financial Results, and Approvals - Research Report on Bristol-Myers Squibb, Merck & Co., Johnson & Johnson, AbbVie, and Novartis
9:00 a.m. Oct. 31, 2013
- PR Newswire

Positive Clinical Trial Results, Patient Enrollment, and Collaborations - Research Report on Pfizer, Medivation, AbbVie, Cigna, and AstraZeneca
9:00 a.m. Oct. 28, 2013
- PR Newswire

Pre-Market Analysis: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc.
10:12 a.m. Oct. 25, 2013
- PR Newswire

AbbVie Reports Third-Quarter 2013 Financial Results
7:54 a.m. Oct. 25, 2013
- PR Newswire

AbbVie Named a Science Top Employer
6:20 p.m. Oct. 24, 2013
- PR Newswire

Financial Results, Quarterly Earnings Schedules, Marketing Authorizations, Completed Acquisitions, and New Drug Applications - Research Report on Johnson & Johnson, AbbVie, GSK, AstraZeneca, and Keryx
8:00 a.m. Oct. 18, 2013
- PR Newswire

OPKO Adds to Growing Technology Portfolio Through Strategic Investment in Biotechnology Company Engaged in the Development of a New Generation of Antibodies
9:00 a.m. Oct. 10, 2013
- BusinessWire

AbbVie to Host Third-Quarter Earnings Conference Call
8:01 a.m. Oct. 4, 2013
- PR Newswire

Under AAAResearchReports.com Microscope: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc.
8:00 a.m. Oct. 4, 2013
- PR Newswire

AbbVie Presents Phase II Data Evaluating the Efficacy of HUMIRA® (adalimumab) in Patients with Hidradenitis Suppurativa (HS), a Chronic Inflammatory Skin Disease
6:00 a.m. Oct. 3, 2013
- PR Newswire

Drug Approvals, Trial Results, and Collaboration- Research Report on Johnson & Johnson, Bristol-Myers Squibb, Eli Lilly, AbbVie, and GSK
8:00 a.m. Sept. 30, 2013
- PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Goodwill's ReThink Fashion: Textiles to Runway Art

Transforming Old to New on the Runway Right when you think fashion's all about the next shiny thing, here comes Goodwill of Delaware & Delaware County flipping the script. Their ReThink Fashion Show - the ECO Edit teaches us a thing or two about what giving old clothes a new life truly means. It's not just about tossing a used tee onto a catwalk but a whole rebirth...

The Austin Company to Showcase at ISPE Annual Event

Setting the Stage at ISPE Expo When you think of pharmaceuticals and the bustle behind closed doors, it's with companies like The Austin Company leading the charge. This October, they're strutting their stuff at the ISPE Annual Meeting and Expo. No small potatoes here—it's at the Gaylord National in Maryland. Mark those dates: October 18-21, 2026. It's a circus of...

LeoLabs and SciTec Partner for $93.7M Space Force Deal

LeoLabs and SciTec Join Forces for Space Dominance The space race ain't just about rockets blasting off anymore. It's about making sure we've got eyes everywhere, even on the back of our heads, so to speak. Enter LeoLabs teaming up with SciTec to help the U.S. Space Force upgrade their radar systems to something out of a sci-fi flick, armed with a $93.7 million contract...

From Kitchen Experiment to U.S. Debut Here's a story that barely fits the tight mold of your typical business textbook. Hair Syrup, born from the brain of a university student tinkering at her kitchen table, is about to make waves across the pond. Lucie Macleod did what many dream of—she took a DIY hair oil project and spun it into a multimillion-dollar brand, now set...

Give Lively & Change Simplify CA Nonprofit Compliance

A Fresh Wind Blowing for California Nonprofits So, here's a twist in the nonprofit world that's stirring the pot just right. Give Lively and Change have partnered up to tackle the thorny issue of regulatory compliance in California. It's a big win for the nonprofits looking to keep fundraising through Give Lively without getting tangled in the bureaucratic web spun up by...

MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

Push Notification Security Transforms Healthcare IT Support

Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...

Spot the Signs: Early Gum Disease Insights from Experts

Why Early Detection of Gum Disease Matters Let's dive right into the crux of things. Gum disease, that sneaky antagonist of oral health, starts unassumingly. You brush, you floss, but those gums might still bleed—ever noticed? Dr. Marian Burgard of Fairport Family Dental has a thing or two to say about this, enlightening us through an insightful piece by HelloNation....

Webinar Highlights Workforce Skills and AI Tools

The Shift Towards Skills-Based Talent Development The labor market's in a whirl, folks. Employers are scrambling to adapt to rapid changes, chasing after 'skills intelligence' like it's going out of style. On September 24, University of Phoenix, with its band of partners including Jobs for the Future and Skillmore™, will dig into this very topic. This upcoming webinar...

Wave Kids™ Unveils New Flavors for Kids' Drinks

Sparking a Fresh Wave in the Kids' Beverage Market Alright, let me tell you about a new player plowing into the kids' drink scene. Wave Kids™, a brand that's making waves—pun intended—has a fresh lineup that screams 'fun' and 'healthy' in equal measure. Just coinciding with back-to-school season, this Scottsdale, Arizona outfit has rolled out not one or two, but...